Vadim Mitrokhin

Dr. Vadim Mitrokhin

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
MMMitko Mladenov
Mitko Mladenov
LLLubomir Lubomirov
Lubomir Lubomirov
OGOlaf Grisk
Olaf Grisk
Dimiter AvtanskiDimiter Avtanski
Dimiter Avtanski
VMVadim Mitrokhin
Vadim Mitrokhin
HGHristo Gagov
Hristo Gagov
This review is focused on the mechanisms that regulate health, disease and aging redox status, the signal pathways that counteract oxidative and reductive stress, the role of food components and additives with antioxidant properties (curcumin, polyphenols, vitamins, carotenoids, flavonoids, etc.), and the role of the hormones irisin and melatonin in the redox homeostasis of animal and human cells. The correlations between the deviation from optimal redox conditions and inflammation, allergic, aging and autoimmune responses are discussed. Special attention is given to the vascular system, kidney, liver and brain oxidative stress processes. The role of hydrogen peroxide as an intracellular and paracrine signal molecule is also reviewed. The cyanotoxins β-N-methylamino-l-alanine (BMAA), cylindrospermopsin, microcystins and nodularins are introduced as potentially dangerous food and environment pro-oxidants.

20 November 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ISIliyana Sazdova
Iliyana Sazdova
Milena Keremidarska-MarkovaMilena Keremidarska-Markova
Milena Keremidarska-Markova
DDDaniela Zdravkova Dimitrova
Daniela Zdravkova Dimitrova
VMVadim Mitrokhin
Vadim Mitrokhin
AKAndre Kamkin
Andre Kamkin
MMMitko Mladenov
Mitko Mladenov
EF24, a synthetic monocarbonyl analog of curcumin, shows significant potential as an anticancer agent with both chemopreventive and chemotherapeutic properties. It exhibits rapid absorption, extensive tissue distribution, and efficient metabolism, ensuring optimal bioavailability and sustained exposure of the target tissues. The ability of EF24 to penetrate biological barriers and accumulate at tumor sites makes it advantageous for effective cancer treatment. Studies have demonstrated EF24’s remarkable efficacy against various cancers, including breast, lung, prostate, colon, and pancreatic cancer. The unique mechanism of action of EF24 involves modulation of the nuclear factor-kappa B (NF-κB) and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathways, disrupting cancer-promoting inflammation and oxidative stress. EF24 inhibits tumor growth by inducing cell cycle arrest and apoptosis, mainly through inhibiting the NF-κB pathway and by regulating key genes by modulating microRNA (miRNA) expression or the proteasomal pathway. In summary, EF24 is a promising anticancer compound with a unique mechanism of action that makes it effective against various cancers. Its ability to enhance the effects of conventional therapies, coupled with improvements in drug delivery systems, could make it a valuable asset in cancer treatment. However, addressing its solubility and stability challenges will be crucial for its successful clinical application.

1 September 2015 in Immunobiology
Verified
Journal Article
Closed access
VMVadim Mitrokhin
Vadim Mitrokhin
MMMitko Mladenov
Mitko Mladenov
AKA.G. Kamkin
A.G. Kamkin

1 July 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
VMVadim Mitrokhin
Vadim Mitrokhin
SAShim AL
Shim AL
AAAksyonov Aa
Aksyonov Aa
ZAZotov As
Zotov As
KAKonev Av
Konev Av
KGKamkin Ga
Kamkin Ga

1 September 2015 in International Immunopharmacology
Verified
Journal Article
Closed access
VMVadim Mitrokhin
Vadim Mitrokhin
MMMitko Mladenov
Mitko Mladenov
AKA.G. Kamkin
A.G. Kamkin

17 May 2024 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
ISIliyana Sazdova
Iliyana Sazdova
NHNikola Hadzi-Petrushev
Nikola Hadzi-Petrushev
MKMilena Keremidarska-Markova
Milena Keremidarska-Markova
Radoslav StojchevskiRadoslav Stojchevski
Radoslav Stojchevski
RSRamadan Sopi
Ramadan Sopi
MMMitko Mladenov
Mitko Mladenov